Möchten Sie immer auf dem neuesten Stand bleiben?

Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key biomarkers in the evaluable 3 mg/kg and 6 mg/kg cohortsAX-0810 demonstrated up...

Hannover, Germany, June 25, 2026 (GLOBE NEWSWIRE) -- EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of...

KNL, owned by Telenor Group, has been appointed as an approved supplier on the United Kingdom's Tactical Communication Systems Framework

WISeKey’s WISeSat.Space Participates in FOSSA Systems Latest Financing Round, Reinforcing its European Secure Satellite Infrastructure Roadmap Investment builds on a four-year relationship with FOSSA...

LIVERMORE, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) announced today that it was added as a member of the US large-cap Russell 1000® Index, effective when the US...

The global conversation on X about the LGBTIQ+ community has fallen by half, while media coverage has declined nearly 10% QoQ over the past three years.The global ecosystem of brands and organizations...

OpenAI & Broadcom unveil Jalapeño–OpenAI’s first Intelligence Processor: an accelerator architected around OpenAI’s vision for the future of LLM inference.

In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing ...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors,...